Kelonia
AcquiredDelivering on the Promise of Genetic Medicine
Boston, United States · Founded 2021 · $50.0M raised
- Headquarters
- Boston, Massachusetts
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B
- Website
- keloniatx.com
- Total Funding
- $50.0M
- Last Round
- $50.0M Series AApr 2022
- Rounds
- 1
- Acquisition Date
- Apr 2026
About
Kelonia Therapeutics is a clinical-stage gene therapy company headquartered in Boston, Massachusetts, focused on in vivo gene delivery to advance a new era of genetic medicines. Founded in 2021, Kelonia is developing proprietary delivery platforms designed to address a broad range of genetic diseases with greater accessibility and scalability than ex vivo approaches. The company's pipeline targets diseases amenable to gene correction, with preclinical and early clinical programs spanning oncology and rare genetic conditions. Kelonia is led by founder and CEO Kevin Friedman, PhD, and backed by investors including Alta Partners and Venrock. The company has assembled a multidisciplinary team of scientists, clinicians, and industry veterans from leading pharma and biotech organizations.
Summary
Kelonia is a Biotech company based in Boston, United States, founded in 2021. It has raised $50.0M in total across 1 round, most recently a $50.0M Series A round in Apr 2022. Investors include Eli Lilly.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Apr 2026
Sign up to see all 2 rounds
Series A through Acquisition — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/kelonia"><img src="https://indexed.vc/api/badge/company/kelonia" alt="Kelonia on Indexed.vc" width="260" height="76" /></a>